HealthRate Awarded "Best in Show" at HIMSS25 Emerge Innovation Experience

Tim Michaels
February 10, 2025
3min Read

HealthRate is honored to announce that we have been named Best in Show in the Emerge Innovation Experience Contest at HIMSS25 for our groundbreaking work in Improving Data & Analytics Capabilities and Reach in the Payer category. This prestigious recognition underscores our commitment to transforming healthcare by delivering data-driven insights that address critical challenges in today's medical landscape.

Addressing Pressing Healthcare Challenges

The healthcare industry is currently facing significant challenges:

  • Escalating Costs of Life-Saving Treatments: The financial burden of essential medical procedures, such as organ transplants, has been steadily increasing. For instance, the median cost of kidney transplantation rose by approximately 23% from 2012 to 2017. Additionally, the number of kidney transplants performed in the United States increased by 52% over the past decade (2012-2022).
  • Rising Demand for Organ Transplants: The need for organ transplants continues to grow, with over 46,000 transplants performed in 2023, marking an 8.7% increase from the previous year.
  • Proliferation of Novel Therapies: The rapid approval of new treatments, including gene and cell therapies, has introduced both opportunities and complexities in patient care. In 2024 alone, the FDA approved 50 novel drugs, reflecting the dynamic nature of medical advancements.

These developments, while promising, present challenges in managing costs and ensuring that self-funded employers and those responsible forcovering life-saving treatments can continue to provide access to care without facing unsustainable financial risk. Today, many self-funded employers and captives are forced to navigate the difficult balance between absorbing high-cost claims and maintaining the financial stability of their organizations—sometimes making decisions that weigh saving a life against preserving heir business.

HealthRate's Innovative Solution

HealthRate addresses these challenges by providing advanced analytic sand proprietary methodologies that offer:

  • Transparent Pricing: Clear insights into the costs of catastrophic claims, enabling better financial planning.
  • Risk Mitigation: Tool to assess and manage the financial risks associated with high-cost treatments.
  • Cost Containment: Strategies to help maintain or minimize premium increases for self-funded employers.

Join Us at HIMSS25

As a Best in Show winner, HealthRate will present its solution live onstage at the HIMSS25 Global Health Conference & Exhibition in Las Vegas, March 3-6, 2025. We invite attendees to join us and explore how our innovative approach is reshaping healthcare analytics.

📅 Presentation Details:

  • Date: March 4, 2025
  • Time: 3:50 PM – 4:35 PM
  • Location: Caesars Forum, Room 131

For media inquiries or to schedule a meeting with HealthRate at HIMSS25, please contact:

Tim Michaels

Chief Executive Officer

612-747-5927

tim@healthrate.io

About HealthRate

HealthRate is an industry-leading data and analytics company specializing in transparent and precise healthcare pricing solutions. We empower stakeholders with accurate cost insights to drive better financial and operational outcomes. Our proprietary approach ensures unmatched visibility into specialty and carve-out network pricing that address catastrophic claims, reducing risk while optimizing healthcare spend.

Follow us on LinkedIn and join the conversation at HIMSS25

Sources:

·        https://srtr.transplant.hrsa.gov/ADR/

·        optn.transplant.hrsa.gov

·        raps.org

Tim Michaels
Insights

Unlocking Insurance Risk Management

Discover valuable insights and tips on managing insurance risks

3 min Read

Don’t Try This at Home: Why DIY Catastrophic Claim Analysis Is Riskier Than You Think

With the rise of healthcare price transparency, open-access data, and AI tools, it’s easy to believe: “We’ve got smart people. We can probably handle this in-house.” We get it. On paper, transplant claims, gene therapies, and bundled pricing don’t look that complicated. But in practice? It’s like watching a YouTube tutorial and deciding to rebuild your transmission. That’s why at HealthRate, we have one simple message for employers, brokers, and TPAs trying to model catastrophic claim risk on their own: “Don’t try this at home.”
3 min Read

The Lottery Paradox: Why Betting Against Rare Healthcare Events Is a Risky Strategy

In philosophy, the Lottery Paradox asks: If you know one ticket will win, but each ticket is unlikely to win, is it rational to believe each ticket will lose? It’s a cautionary tale about how we misjudge low-probability, high-impact events. In healthcare, self-funded employers fall into the same trap every day, especially with organ transplants, gene therapies, and CAR-T treatments. The cost of this thinking? Seven-figure claims that blow past stop-loss.
3 min Read

HealthRate Enhances Transplant Provider Evaluations with Integration of SRTR Quality Data

HealthRate, an award-winning SaaS application specializing in comparing network contracted rates for high-cost medical cases such as transplants, CAR-T, and gene therapy, is proud to announce its integration with the Scientific Registry of Transplant Recipients (SRTR) quality data.

Manage Your Risks Effectively

Try HealthRate today and simplify risk management.